project id: TCGA-HNSC; case submitter id: TCGA-TN-A7HL; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.99; rna integrity number: 8.6; age at index: 59; days to birth: -21731; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21731; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 619.0; icd 10 code: C13.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Hypopharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Hypopharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 45; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-TN-A7HL-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;